Literature DB >> 2258582

Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.

M Lambert1, J Unger, P De Nayer, C Brohet, D Gangji.   

Abstract

Amiodarone-induced thyrotoxicosis (AIT) is generally believed to result from increased hormonal synthesis related to the iodine overload. Thyroid damage has recently been incriminated as a pathophysiological mechanism. We report 3 cases of AIT associated with clinical and/or biochemical features consistent with thyroid damage. This hypothesis was supported by a painful thyroid (case 1), transient high serum Tg (case 2), a transient (case 2) or persistent (case 3) hypothyroid phase and an undetectable technetium thyroid uptake during the hypothyroid period (case 3). These clinical observations support the previous histological data indicating that thyroid follicular disruption might contribute to the pathogenesis of AIT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258582     DOI: 10.1007/bf03348618

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Amiodarone-induced thyroiditis.

Authors:  W H Leung; K K Pun; C P Lau; C K Wong; C Wang
Journal:  Am Heart J       Date:  1989-10       Impact factor: 4.749

2.  Necrosis of follicular cells and discharge of thyroidal iodine induced by administering iodide to iodine-deficient dogs.

Authors:  B E Belshaw; D V Becker
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

3.  Amiodarone-associated thyrotoxicosis masquerading as painful thyroiditis.

Authors:  S L Miaskiewicz; J A Amico; W P Follansbee; G S Levey
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

4.  Pathology of the thyroid in amiodarone-associated thyrotoxicosis.

Authors:  T C Smyrk; J R Goellner; M D Brennan; J A Carney
Journal:  Am J Surg Pathol       Date:  1987-03       Impact factor: 6.394

5.  Serum thyroglobulin concentration may be a clue to the mechanism of amiodarone-induced thyrotoxicosis.

Authors:  J Unger
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

6.  Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate.

Authors:  H H Newnham; D J Topliss; B A Le Grand; N Chosich; R W Harper; J R Stockigt
Journal:  Aust N Z J Med       Date:  1988-02

7.  Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction.

Authors:  E Martino; L Bartalena; S Mariotti; F Aghini-Lombardi; C Ceccarelli; F Lippi; M Piga; A Loviselli; L Braverman; M Safran
Journal:  Acta Endocrinol (Copenh)       Date:  1988-10

8.  Amiodarone: a common source of iodine-induced thyrotoxicosis.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; L Bartalena; L Braverman; A Pinchera
Journal:  Horm Res       Date:  1987

9.  Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases.

Authors:  A F Leger; J P Massin; M F Laurent; M Vincens; M Auriol; O B Helal; G Chomette; J C Savoie
Journal:  Eur J Clin Invest       Date:  1984-12       Impact factor: 4.686

Review 10.  Iodide-induced thyrotoxicosis.

Authors:  J E Fradkin; J Wolff
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

View more
  3 in total

1.  Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.

Authors:  E Cappiello; R Boldorini; A Tosoni; S Piraneo; R Bernasconi; U Raggi
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

2.  Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis.

Authors:  E Roti; L Bianconi; F De Chiara; R Minelli; C Tosi; E Gardini; M Salvi; L E Braverman
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

3.  Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.

Authors:  R Minelli; E Gardini; L Bianconi; M Salvi; E Roti
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.